Morrison Foerster is an international law firm with lawyers practicing throughout the United States, Asia, and Europe. Click to discover more.

mofo_share_image.jpg

Morrison Foerster

common-default.jpeg

Terms / Notices

Cookies

Privacy Policy

Reporting Hotline

Attorney Advertising

Alumni

  Linkedin

MoFo LinkedIN

  Facebook

MoFo Facebook

YouTube

MoFo Youtube

Morrison Foerster - Footer

RILA Members Join Morrison Foerster Discussion on China’s Counter-Sanctions Legal Framework

You have not solved the recaptcha challenge yet or session expired, try again.

Email Disclaimer

Disclaimer

Unsolicited e-mails and information sent to Morrison Foerster will not be considered confidential, may be disclosed to others pursuant to our <a href="https://www.mofo.com/about/privacy-policy.html">Privacy Policy</a>, may not receive a response, and do not create an attorney-client relationship with Morrison Foerster. If you are not already a client of Morrison Foerster, do not include any confidential information in this message. Also, please note that our attorneys do not seek to practice law in any jurisdiction in which they are not properly authorized to do so.

Feedback

mofo-logo-2022.svg

People

Capabilities

Resources

About

Community

Offices

Careers

Stay Connected

On May 14, 2026, Morrison Foerster partner Derik Rao spoke to approximately 50 members of the Retail Industry Leaders Association...

<h3>Sorry, we weren’t able to find the terms you entered.</h3>Please try a different term or keyword.

People

Capabilities

Resources

Not Found Cards

On May 14, 2026, Morrison Foerster partner Derik Rao spoke to approximately 50 members of the Retail Industry Leaders Association (RILA) about China’s evolving counter-sanctions legal framework and its implications for multinational retailers and brands operating global supply chains.The presentation began with an overview of the China Ministry of Commerce (MOFCOM) Blocking Order as of May 2, 2026, China’s counter-sanctions legal framework, and practical implications and risk mitigation approaches for multinational companies. Attendees explored how the new measures may impact compliance programs, supplier relationships, and due diligence activities in China, including supply chain mapping, audits, data collection, and product origin testing. Participants also discussed potential enforcement priorities, practical risk-mitigation strategies, and immediate steps companies may consider taking as the regulatory landscape continues to develop.<hr>

Sign Up

饶宇律师的主要执业领域是合规、监管、制裁、出口管制和白领犯罪事宜，以及与《反海外腐败法》（FCPA）和其他反贿赂法相关的调查事宜。饶律师曾为金融、医疗保健、科技、电讯、加密货币等各行业的跨国公司提供法律意见，也曾代表美国、中国、日本及欧洲的企业处理各类FCPA及其他内部调查事宜，其中涉及商业贿赂、欺诈、数据隐私、挪用公款和违反信托义务的事宜。饶律师在代表跨国医药公司和医疗器械公司开展敏感的调查和设计系统性补救方案方面拥有丰富的经验。饶律师曾协助美国和欧洲领先的医疗保健公司、技术公司、投资组合公司和咨询公司处理亚太地区的一些最敏感和最具影响力的调查，包括涉及监管调查、合规监督、主动披露和在美国司法部（DOJ）进行谈判的事宜。 饶律师还协助银行、投资基金以及其他金融机构管理与制裁有关的风险。此外，饶律师曾在各类证券集体诉讼、监管机构调查及平行诉讼中，为多家纽约证券交易所上市公司进行辩护。他还针对美国刑事和民事诉讼（包括证券集体诉讼、监管调查以及与电信欺诈、内幕交易、经济间谍和盗取知识产权有关的刑事诉讼）为中国大陆、香港地区和新加坡的个人客户进行辩护。在加入美富前，饶律师曾任职于加州帕洛阿尔托某领先的国际律师事务所，就职期间，他曾代表多家领先技术公司处理内部调查和商业诉讼事宜。饶律师毕业于华盛顿大学圣路易斯分校，以优等成绩获得法律博士学位。在就读法学院期间，他曾担任密苏里州联邦法官的外派实习生，期间曾草拟多份意见书。在就读法学院前，他曾在一家国际知名会计师事务所担任资深并购顾问。饶律师精通英语及普通话。<h4>具有代表性的项目</h4><h5>内部和政府调查 </h5><ul><li>代表一家位于美国的世界领先医药公司处理与其在中国、韩国以及欧洲、中东和非洲地区的运营相关的内部调查和补救项目。</li><li>代表一家位于美国的《财富500强》医疗保健公司处理与其在中国的运营相关的各项内部调查事宜，其中涉及反贿赂、挪用公款、数据隐私和会计欺诈等问题。</li><li>代表一家领先的中国通讯科技公司处理与其在亚洲、南美州和非洲的运营相关的若干FCPA内部调查事宜；曾受聘参与公司与美国司法部之间的和解磋商。</li><li>代表一家位于美国的世界领先专业服务公司处理与其在中国的运营相关的多项内部反贿赂调查事宜。</li><li>代表一家领先的中国机构投资者处理在美国多个州进行的若干商业欺诈调查事宜，以及在特拉华州衡平法法院进行的案值达数十亿美元的平行民事审讯事宜。</li><li>代表一家在纳斯达克证券交易所上市的欧洲医疗保险公司处理针对其在中国的运营实施的六个月合规补救项目。</li><li>代表一家位于加州的世界领先通讯公司处理多项技术出口管制与数据隐私调查事宜，协助响应美国司法部及大陪审团的多项传召出庭令。</li><li>代表一家领先的美国农业公司处理与其中国子公司有关的若干内部调查事宜以及相关商业欺诈问题。</li><li>代表一家欧洲跨国医疗器械生产商处理FCPA内部调查事宜。</li><li>代表一家位于欧洲的在纳斯达克证券交易所上市的医疗器械公司处理与其在中国的运营有关的若干内部调查和反贿赂补救事宜。</li><li>代表一家领先的美国财富管理公司响应美国司法部根据《商品交易法》进行的若干调查事宜。</li><li>代表一家在纽约交易所上市的中国区块链公司处理若干商业欺诈调查及相关证券集体诉讼事宜，并为客户的董事会和高级管理人员提供关于美国证券法的合规事务培训。</li></ul><h5>制裁和出口管制 </h5><ul><li>代表一家美国尖端技术公司处理内部调查，涉及其在中国的运营违反出口规定的指控。</li><li>代表一家大型中国银行的香港子公司处理各种商业制裁事宜，包括涉及美国针对俄罗斯、中国大陆、香港特别行政区、伊朗和朝鲜的制裁制度事宜。</li><li>代表一家总部位于亚洲的大型跨国电信服务提供商处理出口管制和商业制裁事宜。</li><li>代表一家《财富》500强中国银行处理有关其香港的运营的各种美国制裁相关事宜。</li><li>代表一家大型中国银行的香港子公司建立制裁合规计划，包括制裁监测工具。</li><li>代表一家中国领先保险公司的海外投资部门处理美国针对俄罗斯、中国大陆和香港特别行政区的制裁制度下的各种事宜。</li><li>代表一家在中国拥有广泛运营的欧洲大型银行评估制裁和出口管制风险并建立制裁合规计划。</li><li>代表一家领先的中国主权财富基金处理由美国发起并针对俄罗斯和中国的制裁相关事宜。</li></ul><h5>诉讼和仲裁</h5><ul><li>代表美国一家大型线上零售平台处理在美国仲裁协会（AAA）进行的一系列有关劳动、就业和零工经济纠纷的仲裁事宜。</li><li>代表一家中国资产管理公司及其美国子公司处理在旧金山高等法院进行的股东纠纷诉讼。</li><li>代表一家中国大型保险集团公司及其美国子公司处理在美国特拉华州衡平法院审理的一项金额达40亿美元的商业合同纠纷，在特拉华州最高法院进行的上诉，以及同时在加州多个州法院进行的反欺诈调查事宜。</li><li>代表一家在纽约证券交易所上市的中国区块链公司处理在美国新泽西州地区法院进行的证券集体诉讼，以及同时进行的内部调查。</li><li>代表加拿大一家大型运输集团公司处理在美国伊利诺伊州中区地方法院进行的合同纠纷。</li></ul>

Derik’s practice primarily focuses on compliance, regulatory, sanctions, export control, and white-collar matters, as well as investigations under the Foreign Corrupt Practices Act (FCPA) and other anti-bribery laws.He has experience advising multinational companies in finance, healthcare, technology, telecommunications, cryptocurrency, and various other industries. Derik represents corporate clients based in the United States, China, Japan, and Europe in various FCPA and other internal investigations, including in matters relating to commercial bribery, fraud, data privacy, embezzlement, and breach of fiduciary duties. He has extensive experience representing multinational pharmaceutical and medical device companies in conducting sensitive investigations and designing systematic remediation programs. Derik has assisted leading healthcare, technology, investment portfolio, and consulting companies based in the United States and Europe in handling some of the most sensitive and impactful investigations in the APAC region, including matters that involve regulatory investigations, compliance monitorships, self-disclosures, and negotiations before the U.S. Department of Justice (DOJ).Derik also assists banks, investment funds, and other financial institutions in managing sanctions-related risks. Additionally, Derik has advised NYSE-listed companies on their defense in securities class actions, regulatory investigations, and parallel lawsuits. Derik also defends individual clients based in Mainland China, Hong Kong, and Singapore in connection with U.S. criminal and civil lawsuits, including securities class actions, regulatory investigations, and criminal lawsuits involving wire fraud, insider trading, economic espionage, and theft of intellectual property.Prior to joining MoFo, Derik worked at a leading international law firm in Palo Alto, California, where he represented various leading technology companies in internal investigations and commercial litigations. He received his J.D. cum laude from Washington University in St. Louis. While in law school, Derik externed for a federal judge in Missouri and drafted multiple opinions. Before law school, Derik was a senior M&A consultant at a world-leading accounting firm.Derik is fluent in English and Mandarin.<h4>Representative Experience</h4><h5>Internal and Government Investigations</h5><ul><li>A world-leading pharmaceutical company based in the United States in various internal investigations and remediation projects concerning its operations in China, South Korea, and EMEA.</li><li>A Fortune 500 healthcare company based in the United States in various internal investigations concerning its operations in China that involve anti-bribery, embezzlement, data privacy, and accounting fraud issues.</li><li>A leading Chinese communication technology company in certain FCPA internal investigations concerning its operations in Asia, South America, and Africa; engaged in settlement negotiations with DOJ.</li><li>A world-leading professional service firm based in the United States in multiple internal anti-bribery investigations concerning its operations in China.</li><li>A leading Chinese institutional investor in certain business fraud investigations in various states in the United States and a parallel multibillion-dollar civil trial before the Delaware Court of Chancery.</li><li>A Europe-based healthcare company listed on the NASDAQ in a six-month compliance remediation project for its operations in China.</li><li>A world-leading communications company based in California in certain technology export control and data privacy investigations in response to various DOJ and grand jury subpoenas.</li><li>A leading U.S. agricultural company in certain internal investigations concerning its subsidiary in China and related commercial fraud issues.</li><li>A multinational European medical device manufacturer in certain FCPA internal investigations.</li><li>A NASDAQ-listed medical device manufacturer based in Europe in certain internal investigations and anti-bribery remediation matters concerning its operations in China.</li><li>A leading U.S. wealth management company in response to certain DOJ investigations under the Commodity Exchange Act.</li><li>A Chinese blockchain company listed on the New York Stock Exchange in certain commercial fraud investigations and a related securities class action; provided compliance training on U.S. securities laws to the client’s board of directors and senior executives.</li></ul><h5>Sanctions and Export Controls</h5><ul><li>A cutting-edge U.S. technology company in an internal investigation concerning alleged export violations relating to its operations in China.</li><li>A large Chinese bank’s subsidiary in Hong Kong in various commercial sanctions matters, including matters that involve U.S. sanctions regimes relating to Russia, Mainland China, Hong Kong SAR, Iran, and North Korea.</li><li>A large multinational telecommunication service provider headquartered in Asia in export control and commercial sanctions matters.</li><li>A Fortune 500 Chinese bank in various U.S. sanctions-related matters concerning its operations in Hong Kong.</li><li>A large Chinese bank’s subsidiary in Hong Kong in establishing a sanctions compliance program, including sanctions monitoring tools.</li><li>A leading Chinese insurance company’s overseas investment function in handling various matters under the U.S. sanctions regimes relating to Russia, Mainland China, and Hong Kong SAR.</li><li>A large Europe-based bank with extensive operations in China in assessing sanctions and export control risks and establishing a sanctions compliance program.</li><li>A leading Chinese sovereign wealth fund in certain matters concerning U.S.-initiated sanctions against Russia and China.</li></ul><h5>Litigation and Arbitration</h5><ul><li>A major U.S. online retail platform in a series of arbitrations concerning labor/employment and gig economy disputes before the American Arbitration Association (AAA).</li><li>A Chinese asset management firm and its U.S. subsidiaries in certain shareholder dispute lawsuits before the San Francisco Superior Court.</li><li>A major Chinese insurance group company and its U.S. subsidiaries in a US$4 billion contract dispute trial before the Delaware Court of Chancery, the appeal before the Delaware Supreme Court, and parallel anti-fraud investigation matters before various California state courts.</li><li>A Chinese block chain company listed on the New York Stock Exchange in a securities class action before the United States District Court for the District of New Jersey, and a parallel internal investigation.</li><li>A major Canadian transportation group company in a contract dispute before the United States District Court for the Central District of Illinois.</li></ul>

RILA Members Join Morrison Foerster Discussion on China’s Counter-Sanctions Legal Framework

14 May 2026